In this video Prof John McMurray (Glasgow University Hospital, Glasgow,UK) and Prof Mikhail Kosiborod (Saint Luke's Mid America Heart Institute, Kansas City, US) discuss the DAPA-HF trial.

This interview is a component of a wider Radcliffe Education programme entitled,'Current and emerging data on SGLT2 inhibitors in heart failure'. Certified accreditation of the full programme is pending following application to the European Board for Accreditation in Cardiology (EBAC). Once accredited the programme will be available on www.radcliffeeducation.com.

Filmed by Radcliffe Cardiology.

Interviewer: Rob Barclay

Videographer: Tom Green